Initiation of Phase IIa Study with ABC294640 (opaganib) for Cholangiocarcinoma at Mayo Clinic and MD Anderson Posted bylwm100 December 22, 2017May 20, 2020 Leave a comment on Initiation of Phase IIa Study with ABC294640 (opaganib) for Cholangiocarcinoma at Mayo Clinic and MD Anderson https://www.redhillbio.com/RedHill/Templates/showpage.asp?DBID=1&LNGID=1&TMID=178&FID=1365&PID=0&IID=6163
